S&P 500   5,167.99 (-0.60%)
DOW   38,215.32 (-0.63%)
QQQ   441.23 (-0.93%)
AAPL   177.47 (+1.39%)
MSFT   424.31 (-0.85%)
META   516.20 (-1.33%)
GOOGL   159.28 (-0.08%)
AMZN   187.98 (-0.57%)
TSLA   172.89 (-0.98%)
NVDA   894.47 (-1.29%)
AMD   162.69 (-4.58%)
NIO   4.23 (-5.16%)
BABA   72.77 (-2.78%)
T   16.43 (+0.06%)
F   12.86 (-1.38%)
MU   124.69 (-2.21%)
GE   156.25 (-0.73%)
CGC   8.17 (+0.25%)
DIS   115.79 (-1.16%)
AMC   2.74 (-2.14%)
PFE   26.26 (-0.30%)
PYPL   65.73 (-0.11%)
XOM   123.54 (+1.44%)
S&P 500   5,167.99 (-0.60%)
DOW   38,215.32 (-0.63%)
QQQ   441.23 (-0.93%)
AAPL   177.47 (+1.39%)
MSFT   424.31 (-0.85%)
META   516.20 (-1.33%)
GOOGL   159.28 (-0.08%)
AMZN   187.98 (-0.57%)
TSLA   172.89 (-0.98%)
NVDA   894.47 (-1.29%)
AMD   162.69 (-4.58%)
NIO   4.23 (-5.16%)
BABA   72.77 (-2.78%)
T   16.43 (+0.06%)
F   12.86 (-1.38%)
MU   124.69 (-2.21%)
GE   156.25 (-0.73%)
CGC   8.17 (+0.25%)
DIS   115.79 (-1.16%)
AMC   2.74 (-2.14%)
PFE   26.26 (-0.30%)
PYPL   65.73 (-0.11%)
XOM   123.54 (+1.44%)
S&P 500   5,167.99 (-0.60%)
DOW   38,215.32 (-0.63%)
QQQ   441.23 (-0.93%)
AAPL   177.47 (+1.39%)
MSFT   424.31 (-0.85%)
META   516.20 (-1.33%)
GOOGL   159.28 (-0.08%)
AMZN   187.98 (-0.57%)
TSLA   172.89 (-0.98%)
NVDA   894.47 (-1.29%)
AMD   162.69 (-4.58%)
NIO   4.23 (-5.16%)
BABA   72.77 (-2.78%)
T   16.43 (+0.06%)
F   12.86 (-1.38%)
MU   124.69 (-2.21%)
GE   156.25 (-0.73%)
CGC   8.17 (+0.25%)
DIS   115.79 (-1.16%)
AMC   2.74 (-2.14%)
PFE   26.26 (-0.30%)
PYPL   65.73 (-0.11%)
XOM   123.54 (+1.44%)
S&P 500   5,167.99 (-0.60%)
DOW   38,215.32 (-0.63%)
QQQ   441.23 (-0.93%)
AAPL   177.47 (+1.39%)
MSFT   424.31 (-0.85%)
META   516.20 (-1.33%)
GOOGL   159.28 (-0.08%)
AMZN   187.98 (-0.57%)
TSLA   172.89 (-0.98%)
NVDA   894.47 (-1.29%)
AMD   162.69 (-4.58%)
NIO   4.23 (-5.16%)
BABA   72.77 (-2.78%)
T   16.43 (+0.06%)
F   12.86 (-1.38%)
MU   124.69 (-2.21%)
GE   156.25 (-0.73%)
CGC   8.17 (+0.25%)
DIS   115.79 (-1.16%)
AMC   2.74 (-2.14%)
PFE   26.26 (-0.30%)
PYPL   65.73 (-0.11%)
XOM   123.54 (+1.44%)

Sensus Healthcare (SRTS) Competitors

$3.31
+0.17 (+5.41%)
(As of 09:31 AM ET)

SRTS vs. ICCM, HSAQ, GBS, NSPR, XAIR, CTSO, APYX, PDEX, CTCX, and DXR

Should you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include IceCure Medical (ICCM), Health Sciences Acquisitions Co. 2 (HSAQ), GBS (GBS), InspireMD (NSPR), Beyond Air (XAIR), Cytosorbents (CTSO), Apyx Medical (APYX), Pro-Dex (PDEX), Carmell (CTCX), and Daxor (DXR). These companies are all part of the "surgical & medical instruments" industry.

Sensus Healthcare vs.

IceCure Medical (NASDAQ:ICCM) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership, community ranking and risk.

Sensus Healthcare has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.23M17.65-$14.65M-$0.33-3.79
Sensus Healthcare$24.41M2.11$490K$0.03104.67

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 11.1% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

IceCure Medical currently has a consensus target price of $2.95, suggesting a potential upside of 136.00%. Sensus Healthcare has a consensus target price of $7.50, suggesting a potential upside of 138.85%. Given IceCure Medical's higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than IceCure Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Sensus Healthcare
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Sensus Healthcare has a net margin of 1.99% compared to Sensus Healthcare's net margin of -453.76%. IceCure Medical's return on equity of 1.04% beat Sensus Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-453.76% -86.96% -68.63%
Sensus Healthcare 1.99%1.04%0.93%

In the previous week, IceCure Medical had 10 more articles in the media than Sensus Healthcare. MarketBeat recorded 14 mentions for IceCure Medical and 4 mentions for Sensus Healthcare. IceCure Medical's average media sentiment score of 1.46 beat Sensus Healthcare's score of 0.38 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IceCure Medical
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sensus Healthcare
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sensus Healthcare received 160 more outperform votes than IceCure Medical when rated by MarketBeat users. However, 94.12% of users gave IceCure Medical an outperform vote while only 67.69% of users gave Sensus Healthcare an outperform vote.

CompanyUnderperformOutperform
IceCure MedicalOutperform Votes
16
94.12%
Underperform Votes
1
5.88%
Sensus HealthcareOutperform Votes
176
67.69%
Underperform Votes
84
32.31%

IceCure Medical has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500.

Summary

Sensus Healthcare beats IceCure Medical on 13 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRTS vs. The Competition

MetricSensus HealthcareSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$51.48M$3.84B$5.04B$7.77B
Dividend YieldN/A2.18%2.94%3.87%
P/E Ratio104.7021.33276.6219.29
Price / Sales2.1160.702,378.46105.54
Price / Cash62.0046.5835.5732.13
Price / Book1.054.554.694.40
Net Income$490,000.00-$476,711.41$104.32M$215.04M
7 Day Performance-8.99%-0.93%-0.60%-0.62%
1 Month Performance-11.55%-3.55%-0.31%0.14%
1 Year Performance-38.19%16.63%18.49%11.93%

Sensus Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICCM
IceCure Medical
1.7046 of 5 stars
$1.25
flat
$2.95
+136.0%
+11.6%$57.03M$3.23M-3.7965Short Interest ↑
HSAQ
Health Sciences Acquisitions Co. 2
0 of 5 stars
$4.89
-0.8%
N/A-77.0%$54.83MN/A0.004News Coverage
GBS
GBS
0 of 5 stars
$3.62
-3.7%
N/A+15.5%$53.90M$440,000.00-6.467Gap Up
NSPR
InspireMD
1.2682 of 5 stars
$2.28
-2.6%
$4.85
+112.7%
+111.0%$53.48M$6.21M-2.1165
XAIR
Beyond Air
3.2837 of 5 stars
$1.67
+3.7%
$11.25
+573.7%
-77.1%$60.19MN/A-0.7898Short Interest ↑
CTSO
Cytosorbents
1.429 of 5 stars
$0.98
+2.1%
$2.50
+155.1%
-72.8%$52.25M$31.08M-1.53198Positive News
APYX
Apyx Medical
4.4007 of 5 stars
$1.47
+0.7%
$6.17
+319.5%
-53.6%$50.92M$52.35M-2.72252Short Interest ↓
Positive News
PDEX
Pro-Dex
0 of 5 stars
$17.82
-1.6%
N/A+11.1%$62.55M$46.09M23.76145Short Interest ↓
News Coverage
CTCX
Carmell
0 of 5 stars
$2.47
-8.2%
N/AN/A$47.52MN/A0.0014News Coverage
Gap Down
DXR
Daxor
0 of 5 stars
$9.74
+2.1%
N/AN/A$46.17MN/A0.00N/AShort Interest ↓
Gap Up

Related Companies and Tools

This page (NASDAQ:SRTS) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners